Brainsway Long Term Debt 2018-2025 | BWAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Brainsway long term debt from 2018 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Brainsway long term debt from 2018 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$215.2B
Boston Scientific (BSX)	$153.3B
Stryker (SYK)	$148.6B
EssilorLuxottica (ESLOY)	$131.1B
Medtronic (MDT)	$114.9B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.1B
ResMed (RMD)	$37.8B
GE HealthCare Technologies (GEHC)	$34.8B
Agilent Technologies (A)	$32.4B
Terumo (TRUMY)	$23.9B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$20B
Zimmer Biomet Holdings (ZBH)	$18.4B
Baxter (BAX)	$14.3B
Smith & Nephew SNATS (SNN)	$13.2B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$4.9B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.7B
Haemonetics (HAE)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.4B
Acuren (TIC)	$1.4B